Claims for Patent: 4,483,807
✉ Email this page to a colleague
Summary for Patent: 4,483,807
Title: | Process for producing a slow release composite |
Abstract: | A process is herein disclosed for producing a slow release composite comprising grinding and mixing mechanically in a frozen state one or more polypeptides, one or more proteins and one or more physiologically active substances shaping the blend into a desired form and compressing at a pressure of from 100 to 20,000 kg/cm.sup.2 to thereby produce a slow release composite having the physiologically active substances encapsulated therein. |
Inventor(s): | Asano; Masaharu (Gunma, JP), Yoshida; Masaru (Gunma, JP), Kaetsu; Isao (Gunma, JP) |
Assignee: | Japan Atomic Energy Research Institute (Tokyo, JP) |
Application Number: | 06/340,989 |
Patent Claims: | 1. A process for producing a slow release composite having a physiologicaly active substance encapsulated therein, wherein a system comprising
one or more polypeptides selected from the group consisting of poly-alanine, poly-glycine, poly-valine, poly-leucine, polyisoleucine, poly-serine, poly-o-benzyl-serine, poly-threonine, poly-o-benzyl-threonine, poly-cysteine, poly-s-benzyl-cysteine, poly-cystine, poly-methionine, poly-proline, poly-oxyproline, poly-aspartic acid, poly-.beta.-benzyl-aspartic acid, poly-glutamic acid, poly-.gamma.-benzyl-glutamic acid, poly-.gamma.-methyl-glutamic acid, poly-histidine, poly-lysine, poly-oxylysine, poly-ornithine, poly-arginine, poly-nitroalginine, poly-phenylalanine, poly-tyrosine, poly-o-benzyl-tyrosine, and polytryptophan, one or more proteins selected from the group consisting of starch, beta-globulin, gamma-globulin, albumen albumin, milk albumin, bovine serum albumin, human serum albumin, other serum albumins, leucosin, hemoglobin, globin, alpha-lipoprotein, beta-lipoprotein, fibrinogen, ovalbumin, conalbumin euglobulin, pseudoglobulin, glutenin, gliadin, insulin, glutathione, pectin, albumen, prolamine, glutelin, histone, protamine, metaprotein, peptone, myoglobin, ferritin, bacteriorhodopsin, rubredoxin, chymotrypsin, ribonuclease, papain, thermolysin, thioredoxin, flavodoxin, hexokinase, phosphorylase, carboxypeptidase A, albumen lysozyme, cytochrome, thrombin, elastase, pepsin, elastin, and protamine, and one or more physiologically active substances is ground into particles and mixed mechanicaly in a frozen state, the blend is shaped into a suitable form, and the shaped article is compressed into a suitable form at a pressure of from 100 to 20,000 kg/cm.sup.2. 2. A process for producing a slow release composite having physiologically active substance encapsulated therein, wherein a system comprising one or more polypeptides selected from the group consisting of poly-alanine, poly-glycine, poly-valine, poly-leucine, polyisoleucine, poly-serine, poly-o-benzyl-serine, poly-threonine, poly-o-benzyl-threonine, poly-cysteine, poly-s-benzyl-cysteine, poly-cystine, poly-methionine, poly-proline, poly-oxyproline, poly-aspartic acid, poly-.beta.-benzyl-aspartic acid, poly-glutamic acid, poly-.gamma.-benzyl-glutamic acid, poly-.gamma.-methyl-glutamic acid, poly-histidine, poly-lysine, poly-oxylysine, poly-ornithine, poly-arginine, poly-nitroalginine, poly-phenylalanine, poly-tyrosine, poly-o-benzyl-tyrosine, and polytryptophan, one or more proteins selected from the group consisting of starch, beta-globulin, gamma-globulin, albumen albumin, milk albumin, bovine serum albumin, human serum albumin, other serum albumins, leucosin, hemoglobin, globin, alpha-lipoprotein, beta-lipoprotein, fibrinogen, ovalbumin, conalbumin euglobulin, pseudoglobulin, glutenin, gliadin, insulin, glutathione, pectin, albumen, prolamine, glutelin, histone, protamine, metaprotein, peptone, myoglobin, ferritin, bacteriorhodopsin, rubredoxin, chymotrypsin, ribonuclease, papain, thermolysin, thioredoxin, flavodoxin, hexokinase, phosphorylase, carboxypeptidase A, albumen lysozyme, cytochrome, thrombin, elastase, pepsin, elastin, and protamine, and one or more physiologically active substances is ground into particles and mixed mechanically in a frozen state, the blend is shaped into a suitable the shaped article is compressed into a suitable form at a pressure of from 100 to 20,000 kg/cm.sup.2, said shaped article being irradiated with light or ionizing radiation as it is compressed or after it has been compressed at a pressure of from 100 to 20,000 kg/cm.sup.2. 3. A process for producing a slow release composite having physiologically active substance encpsulated therein, wherein a system comprising one or more polypeptides selected from the group consisting of poly-aniline, poly-glycine, poly-valine, poly-leucine, polyisoleucine, poly-serine, poly-o-benzyl-serine, poly-threonine, poly-o-benzyl-threonine, poly-cysteine, poly-s-benzyl-cysteine, poly-cystine, poly-methionine, poly-proline, poly-oxyproline, poly-aspartic acid, poly-.beta.-benzyl-aspartic acid, poly-glutamic acid, poly-.gamma.-benzyl-glutamic acid, poly-.gamma.-methyl-glutamic acid, poly-histidine, poly-lysine, poly-oxylysine, poly-ornithine, poly-arginine, poly-nitroalginine, poly-phenylalanine, poly-tyrosine, poly-o-benzyl-tyrosine, and polytryptophan, one or more proteins selected from the group consisting of starch, beta-globulin, gamma-globulin, albumen albumin, milk albumin, bovine serum albumin, human serum albumin, other serum albumins, leucosin, hemoglobin, globin, alpha-lipoprotein, beta-lipoprotein, fibrinogen, ovalbumin, conalbumin euglobulin, pseudoglobulin, glutenin, gliadin, insulin, glutathione, pectin, albumen, prolamine, glutelin, histone, protamine, metaprotein, peptone, myoglobin, ferritin, bacteriorhodopsin, rubredoxin, chymotrypsin, ribonuclease, papain, thermolysin, thioredoxin, flavodoxin, hexokinase, phosphorylase, carboxypeptidase A, albumen lysozyme, cytochrome, thrombin, elastase, pepsin, elastin, and protamine. one or more physiologically active substances, and a suitable mixture of water and an organic solvent is shaped into a suitable form, and the shaped article is heated at a temperature between room temperature and 100.degree. C. 4. A process for producing a slow release composite having a physiologically active substance encapsulated therein, wherein a system comprising one or more polypeptides selected from the group consisting of poly-alanine, poly-glycine, poly-valine, poly-leucine, polyisoleucine, poly-serine, poly-o-benzyl-serine, poly-threonine, poly-o-benzyl-threonine, poly-cysteine, poly-s-benzyl-cysteine, poly-cystine, poly-methionine, poly-proline, poly-oxyproline, poly-aspartic acid, poly-.beta.-benzyl-aspartic acid, poly-glutamic acid, poly-.gamma.-benzyl-glutamic acid, poly-.gamma.-methyl-glutamic acid, poly-histidine, poly-lysine, poly-oxylysine, poly-ornithine, poly-arginine, poly-nitroalginine, poly-phenylalanine, poly-tyrosine, poly-o-benzyl-tyrosine, and polytryptophan, one or more proteins selected from the group consisting of starch, beta-globulin, gamma-globulin, albumen albumin, milk albumin, bovine serum albumin, human serum albumin, other serum albumins, leucosin, hemoglobin, globin, alpha-lipoprotein, beta-lipoprotein, fibrinogen, ovalbumin, conalbumin euglobulin, pseudoglobulin, glutenin, gliadin, insulin, glutathione, pectin, albumen, prolamine, glutelin, histone, protamine, metaprotein, peptone, myoglobin, ferritin, bacteriorhodopsin, rubredoxin, chymotrypsin, ribonuclease, papain, thermolysin, thioredoxin, flavodoxin, hexokinase, phosphorylase, carboxypeptidase A, albumen lysozyme, cytochrome, thrombin, elastase, pepsin, elastin, and protamine, one or more physiologically active substances, and a suitable mixture of water and an organic solvent is shaped into a suitable form, and the shaped article is heated at a temperature between room temperature and 100.degree. C., and the heated product is further irradiated with light or ionizing radiation. |
Details for Patent 4,483,807
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Grifols Therapeutics Llc | ALBUKED, PLASBUMIN-20, PLASBUMIN-25, PLASBUMIN-5 | albumin (human) | For Injection | 101138 | 10/21/1942 | ⤷ Try a Trial | 2001-11-20 |
Baxalta Us Inc. | BUMINATE, FLEXBUMIN | albumin (human) | Injection | 101452 | 03/03/1954 | ⤷ Try a Trial | 2001-11-20 |
Csl Behring Ag | ALBURX | albumin (human) | Injection | 102366 | 07/23/1976 | ⤷ Try a Trial | 2001-11-20 |
Grifols Biologicals Llc | ALBUTEIN | albumin (human) | Injection | 102478 | 08/15/1978 | ⤷ Try a Trial | 2001-11-20 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.